Timeline

François Anna
PhD Student
10 Jun 2024
publication

T-cell immunity induced and reshaped by an anti-HPV immuno-oncotherapeutic lentiviral vector.

Read more
07 Sep 2023
publication

Full eradication of pre-clinical human papilloma virus-induced tumors by a lentiviral vaccine.

Read more
18 Apr 2023
publication

Mice Humanized for MHC and hACE2 with High Permissiveness to SARS-CoV-2 Omicron Replication.

Read more
21 Dec 2022
publication

Full-Lung Prophylaxis against SARS-CoV-2 by One-Shot or Booster Intranasal Lentiviral Vaccination in Syrian Golden Hamsters

Read more
14 Sep 2022
publication

A lentiviral vector expressing a dendritic cell-targeting multimer induces mucosal anti-mycobacterial CD4+ T-cell immunity.

Read more
26 Jul 2022
publication

A lentiviral vector encoding fusion of light invariant chain and mycobacterial antigens induces protective CD4+ T cell immunity.

Read more
27 Apr 2022
publication

An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa.

Read more
07 Dec 2021
publication

Brain cross-protection against SARS-CoV-2 variants by a lentiviral vaccine in new transgenic mice.

Read more
29 Jul 2021
team

Institut Pasteur-TheraVectys Joint Laboratory

Read more
26 Jul 2021
news

Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France

Read more
02 Sep 2020
publication

A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations

Read more